TY - JOUR
T1 - Sex differences in dementia with Lewy bodies
T2 - Focused review of available evidence and future directions
AU - Chiu, Shannon Y.
AU - Wyman-Chick, Kathryn A.
AU - Ferman, Tanis J.
AU - Bayram, Ece
AU - Holden, Samantha K.
AU - Choudhury, Parichita
AU - Armstrong, Melissa J.
N1 - Funding Information:
Dr. Chiu receives research support from the NIH (K23AG073525-01A1). Dr. Wyman-Chick receives research support from the NIH (R21AG074368). Dr. Ferman is supported by NIH U01NS100620, U19AG71754, P30AG62677 and from the Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program. Dr. Bayram receives research support from the NIH (K99AG073453). Dr. Holden receives research support from the NIH (R21AG072153) and as the local PI of a Lewy Body Dementia Association Research Center of Excellence. Dr. Choudhury receives research support from Lewy Body Dementia Association and Arizona Alzheimer's Research Consortium. Dr. Armstrong receives research support from the NIH (R01AG068128, P30AG047266, R01NS121099, R44AG062072), the Florida Department of Health (grant 20A08), and as the local PI of a Lewy Body Dementia Association Research Center of Excellence. She serves on the DSMBs for the Alzheimer's Therapeutic Research Institute/Alzheimer's Clinical Trial Consortium and the Alzheimer's Disease Cooperative Study.
Funding Information:
Co-authors on this review have Lewy body dementia grants from the National Institutes of Health ( K23AG073525-01A1 , R21AG074368 , K99AG073453 , R01AG068128 , P30AG047266 , U01NS100620 ), which in part supported this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Funding Information:
Co-authors on this review have Lewy body dementia grants from the National Institutes of Health (K23AG073525-01A1, R21AG074368, K99AG073453, R01AG068128, P30AG047266, U01NS100620), which in part supported this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Dr. Chiu receives research support from the NIH (K23AG073525-01A1). Dr. Wyman-Chick receives research support from the NIH (R21AG074368). Dr. Ferman is supported by NIH U01NS100620, U19AG71754, P30AG62677 and from the Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program. Dr. Bayram receives research support from the NIH (K99AG073453). Dr. Holden receives research support from the NIH (R21AG072153) and as the local PI of a Lewy Body Dementia Association Research Center of Excellence. Dr. Choudhury receives research support from Lewy Body Dementia Association and Arizona Alzheimer's Research Consortium. Dr. Armstrong receives research support from the NIH (R01AG068128, P30AG047266, R01NS121099, R44AG062072), the Florida Department of Health (grant 20A08), and as the local PI of a Lewy Body Dementia Association Research Center of Excellence. She serves on the DSMBs for the Alzheimer's Therapeutic Research Institute/Alzheimer's Clinical Trial Consortium and the Alzheimer's Disease Cooperative Study.
Publisher Copyright:
© 2023 Elsevier Ltd
PY - 2023/2
Y1 - 2023/2
N2 - In this review, we summarize the current knowledge on sex differences in dementia with Lewy bodies (DLB) relating to epidemiology, clinical features, neuropathology, biomarkers, disease progression, and caregiving. While many studies show a higher DLB prevalence in men, this finding is inconsistent and varies by study approach. Visual hallucinations may be more common and occur earlier in women with DLB, whereas REM sleep behavior disorder may be more common and occur earlier in men. Several studies report a higher frequency of parkinsonism in men with DLB, while the frequency of fluctuations appears similar between sexes. Women tend to be older, have greater cognitive impairment at their initial visit, and are delayed in meeting DLB criteria compared to men. Women are also more likely to have Lewy body disease with co-existing AD-related pathology than so-called “pure” Lewy body disease, while men may present with either. Research is mixed regarding the impact of sex on DLB progression. Biomarker and treatment research assessing for sex differences is lacking. Women provide the majority of caregiving in DLB but how this affects the caregiving experience is uncertain. Gaining a better understanding of sex differences will be instrumental in aiding future development of sex-specific strategies in DLB for early diagnosis, care, and drug development.
AB - In this review, we summarize the current knowledge on sex differences in dementia with Lewy bodies (DLB) relating to epidemiology, clinical features, neuropathology, biomarkers, disease progression, and caregiving. While many studies show a higher DLB prevalence in men, this finding is inconsistent and varies by study approach. Visual hallucinations may be more common and occur earlier in women with DLB, whereas REM sleep behavior disorder may be more common and occur earlier in men. Several studies report a higher frequency of parkinsonism in men with DLB, while the frequency of fluctuations appears similar between sexes. Women tend to be older, have greater cognitive impairment at their initial visit, and are delayed in meeting DLB criteria compared to men. Women are also more likely to have Lewy body disease with co-existing AD-related pathology than so-called “pure” Lewy body disease, while men may present with either. Research is mixed regarding the impact of sex on DLB progression. Biomarker and treatment research assessing for sex differences is lacking. Women provide the majority of caregiving in DLB but how this affects the caregiving experience is uncertain. Gaining a better understanding of sex differences will be instrumental in aiding future development of sex-specific strategies in DLB for early diagnosis, care, and drug development.
KW - Dementia
KW - Dementia with Lewy bodies
KW - Lewy body disease
KW - Sex
UR - http://www.scopus.com/inward/record.url?scp=85147337732&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147337732&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2023.105285
DO - 10.1016/j.parkreldis.2023.105285
M3 - Review article
C2 - 36682958
AN - SCOPUS:85147337732
SN - 1353-8020
VL - 107
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
M1 - 105285
ER -